Plain-English translation of NCT04606732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at the University of Bologna are studying how COVID-19 pneumonia affects the heart and which heart-related treatments work best for patients who are hospitalized. By collecting information from 2,000 hospitalized patients, they hope to better understand why some people recover well while others have heart complications, so doctors can provide better care in the future.
When people get severe COVID-19 pneumonia, their hearts can be affected in serious ways — but we don't fully understand which treatments help the most or how to predict which patients will have the worst outcomes. This study exists to close that gap so doctors can make better decisions for the next patients who need care.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect information from your medical records during and after your hospital stay — including details about your heart health, any treatments you receive, and how you recover. This is an observational study, meaning researchers watch and record what happens naturally rather than assigning you to take a new medication. Your participation helps doctors learn what works best for future patients.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Italy
~2,000 participants
Started
September 2020
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Olivia Manfrini, MD
DIMEC, Università di Bologna
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.